当前位置: X-MOL 学术Lancet Diabetes Endocrinol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Research in brief
The Lancet Diabetes & Endocrinology ( IF 44.5 ) Pub Date : 2017-10-11 , DOI: 10.1016/s2213-8587(17)30337-6
Seema Kang

In a post-hoc analysis using data from the ACCORD-BP study, Buckley and colleagues assessed the impact of intensive control of blood pressure in people with type 2 diabetes with cardiovascular risk factors. Participants from the ACCORD-BP study who met the inclusion criteria for the SPRINT study were included in the analysis. Researchers calculated the event rate for the primary composite cardiovascular outcome (cardiovascular death, stroke, non-fatal myocardial infarction or stroke, or revascularisation) as 3·48% per year in the intensive blood pressure control group compared with 4·22% per year in the standard control group (HR 0·79, 95% CI 0·65–0·96; p=0·02).

中文翻译:

研究简述

在使用ACCORD-BP研究数据进行的事后分析中,Buckley及其同事评估了强化控制血压对具有心血管危险因素的2型糖尿病患者的影响。符合SPRINT研究纳入标准的ACCORD-BP研究参与者被纳入分析。研究人员计算出,在高血压控制组中,主要复合心血管事件(心血管死亡,中风,非致命性心肌梗塞或中风或血运重建)的发生率为每年3·48%,而每年为4·22%在标准对照组中(HR 0·79,95%CI 0·65-0·96; p = 0·02)。
更新日期:2017-11-10
down
wechat
bug